Skip to main content
Livermore
Livermore
ZHEN

Acrivon Therapeutics, Inc.

ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001781174

In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Acrivon Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
0 vs. Q3 2025
Shares held
18.6M
+1.09M (+6.2%) vs. Q3 2025
Total value
$44.9M
+$13.2M (+41.6%) vs. Q3 2025
New holders
8
16 more added
Sold out
8
10 more reduced

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 48 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 18 institutionsQ1 2023: 39 institutionsQ2 2023: 40 institutionsQ3 2023: 43 institutionsQ4 2023: 42 institutionsQ1 2024: 48 institutionsQ2 2024: 55 institutionsQ3 2024: 55 institutionsQ4 2024: 63 institutionsQ1 2025: 63 institutionsQ2 2025: 53 institutionsQ3 2025: 48 institutionsQ4 2025: 48 institutionsQ1 2026: 44 institutionsQ2 2026: 46 institutions
Value heldQ4 2025: $44.9M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $170.4MQ1 2023: $191.1MQ2 2023: $196.0MQ3 2023: $144.3MQ4 2023: $74.5MQ1 2024: $109.0MQ2 2024: $136.1MQ3 2024: $160.8MQ4 2024: $140.0MQ1 2025: $45.7MQ2 2025: $21.2MQ3 2025: $31.7MQ4 2025: $44.9MQ1 2026: $22.6MQ2 2026: $38.1M
Institutions holding ACRV and their total value by quarter
QuarterHoldersValue
Q2 202646$38.1M
Q1 202644$22.6M
Q4 202548$44.9M
Q3 202548$31.7M
Q2 202553$21.2M
Q1 202563$45.7M
Q4 202463$140.0M
Q3 202455$160.8M
Q2 202455$136.1M
Q1 202448$109.0M
Q4 202342$74.5M
Q3 202343$144.3M
Q2 202340$196.0M
Q1 202339$191.1M
Q4 202218$170.4M
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q3 2025.

Institutions holding ACRV in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.8,340,508$20.1M0.21%00.0%Unchanged
Sands Capital Ventures, LLC2,122,605$5.12M0.99%00.0%Unchanged
Citadel Advisors LLC1,641,884$3.96M0.00%+100,558+6.5%Added
Wellington Management Group LLP888,130$2.14M0.00%00.0%Unchanged
Vanguard Group Inc698,857$1.68M0.00%+72,709+11.6%Added
Renaissance Technologies LLC634,169$1.53M0.00%+10,769+1.7%Added
Two Sigma Investments, LP585,069$1.41M0.00%+265,864+83.3%Added
Acadian Asset Management LLC581,208$1.40M0.00%+489,204+531.7%Added
Marshall Wace, LLP496,081$1.20M0.00%+346,366+231.4%Added
Acorn Capital Advisors, LLC405,237$976.6K0.33%00.0%Unchanged
UBS Group AG348,541$840.0K0.00%−334,677−49.0%Reduced
Jane Street Group, LLC342,071$824.4K0.00%+52,823+18.3%Added
Two Sigma Advisers, LP333,773$804.4K0.00%+197,273+144.5%Added
BlackRock, Inc.205,124$494.3K0.00%−125,833−38.0%Reduced
Geode Capital Management, LLC198,223$477.9K0.00%+6,190+3.2%Added
Millennium Management LLC121,524$292.9K0.00%−63,710−34.4%Reduced
Goldman Sachs Group Inc119,422$287.8K0.00%+99,680+504.9%Added
State Street Corp67,145$161.8K0.00%00.0%Unchanged
Northern Trust Corp63,718$153.6K0.00%+21,552+51.1%Added
Prelude Capital Management, LLC48,015$115.7K0.01%+48,015New
Morgan Stanley46,831$112.9K0.00%−10,329−18.1%Reduced
Bridgeway Capital Management, LLC42,900$103.4K0.00%+20,000+87.3%Added
Squarepoint Ops LLC26,162$63.0K0.00%−78,162−74.9%Reduced
Barclays PLC24,402$58.8K0.00%+4,437+22.2%Added
Baker Bros. Advisors LP22,809$55.0K0.00%00.0%Unchanged
Quadrature Capital Ltd20,730$50.0K0.00%+20,730New
XTX Topco Ltd20,572$49.6K0.00%−15,383−42.8%Reduced
Dimensional Fund Advisors LP18,364$44.3K0.00%−1,215−6.2%Reduced
Vermillion & White Wealth Management Group, LLC18,100$43.6K0.02%+18,100New
Bank of America Corp17,447$42.0K0.00%−1,457−7.7%Reduced
JPMorgan Chase & Co16,864$40.6K0.00%+15,123+868.6%Added
Schonfeld Strategic Advisors LLC16,428$39.6K0.00%+16,428New
Citigroup Inc14,592$35.2K0.00%−1,713−10.5%Reduced
Susquehanna International Group, LLP12,433$30.0K0.00%+12,433New
Point72 Asset Management, L.P.10,876$26.2K0.00%+10,876New
AAFCPAs Wealth Management, LLC10,678$25.7K0.01%00.0%Unchanged
Marex Group plc10,000$24.1K0.00%+10,000New
FMR LLC8,622$20.8K0.00%00.0%Unchanged
Federated Hermes, Inc.5,612$13.5K0.00%+3,186+131.3%Added
Royal Bank of Canada1,711$4.00K0.00%+763+80.5%Added
BNP Paribas Arbitrage, SA634$1.53K0.00%−555−46.7%Reduced
Nisa Investment Advisors, LLC584$1.41K0.00%00.0%Unchanged
Redwood Park Advisors LLC500$1.21K0.00%00.0%Unchanged
Russell Investments Group, Ltd.481$1.16K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec400$9640.00%00.0%Unchanged
EverSource Wealth Advisors, LLC373$8990.00%00.0%Unchanged
Optima Capital LLC278$6700.00%+278New
SBI Securities Co., Ltd.74$1780.00%00.0%Unchanged
Algert Global LLC0$00.00%−44,648−100.0%Sold out
Bluefin Capital Management, LLC0$00.00%−42,039−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−8,736−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−5,514−100.0%Sold out
Mirae Asset Global Investments Co., Ltd.0$00.00%−1,216−100.0%Sold out
GF Fund Management Co. Ltd.0$00.00%−650−100.0%Sold out
CWM, LLC0$00.00%−127−100.0%Sold out
Colony Group, LLC0$00.00%−19,846−100.0%Sold out